Mitochondrial peptides are where most people get it wrong, and the order matters more than the dose. Barry Napier and Dr. Angila Jaeggli ND break down SS-31, methylene blue and MOTS-c: what each one actually does, why stacking them blindly can flatten your energy instead of lifting it, and the sequence that works. What we cover: - What SS-31 does for the mitochondria, and why it comes first - Methylene blue: dose, timing, and the interaction nobody warns you about - MOTS-c, and why it makes some people tired - The correct order to run them, and how long to stay on each - The lab markers worth tracking Full show notes: bodymindbiz.com

Are you ready to unlock your body's full potential and finally build a peptide stack that delivers real results? Stop guessing and start optimizing with our comprehensive guide to creating the perfect peptide regimen tailored to YOUR specific goals. We dive deep into the world of peptides, revealing the science, strategies, and secrets behind building synergistic stacks for everything from muscle gain and fat loss to anti-aging and cognitive enhancement. We cut through the confusion, helping you understand which peptides work best together, how to dose them safely, and where to find reliable sources. What we cover: - Why most peptide stacks fail - How to pick compounds that work together instead of against each other - Stacks for fat loss, muscle, recovery and longevity - Dosing and sourcing without getting burned Full show notes: bodymindbiz.com

What else should you be running when you're on a GLP-1? It's the number one question we get, from practitioners and patients alike. If you're on tirzepatide or retatrutide and you've hit a plateau, lost your energy, or you're worried about losing muscle along with the fat, this episode is the full map. Barry Napier and Dr. Angila Jaeggli, ND walk through every compound they actually use alongside a GLP-1, what each one does, which ones are worth it, and which two they tell people to skip entirely. What we cover: - Why muscle loss is the real risk on a GLP-1 - The compounds they run alongside tirzepatide and retatrutide - What to do when you hit a plateau - The two they tell people to skip Full show notes: bodymindbiz.com